Johnson Fistel Investigates Encompass Health Following Reports Of Poor Patient Outcomes At Rehab Facilities
What if I purchased Encompass Health securities?
If you suffered losses, you may be eligible to participate in a class action or seek recovery:
For more information, contact James Baker at (619) 814-4471, ... or ....
Background:
On July 15, 2025, The New York Times published an article titled "Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed," reporting that Encompass Health "accounts for about one in seven rehab facilities nationally, but owned 34 of the 41 inpatient rehab facilities that Medicare rated as having statistically significantly worse rates of potentially preventable readmissions for discharged patients" and that Encompass Health "owned 28 of the 87 rehab facilities – 65 of which were for-profit – that had worse rates of potentially preventable readmissions to general hospitals during patient stays." Following this news, the price of Encompass Health stock fell by more than 10%.
About Johnson Fistel, PLLP:
Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in securities class actions and shareholder derivative lawsuits, including foreign investors on U.S. exchanges. In 2024, it was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, recovering approximately $90.7 million for clients where it served as lead or co-lead counsel. For more information, visit
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq.
(619) 814-4471
... or ...


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- United States Lubricants Market Growth Opportunities & Share Dynamics 20252033
- Daytrading Publishes New Study On The Dangers Of AI Tools Used By Traders
- Newcastle United Announce Multi-Year Partnership With Bydfi
- Ecosync & Carboncore Launch Full Stages Refi Infrastructure Linking Carbon Credits With Web3
- Utila Triples Valuation In Six Months As Stablecoin Infrastructure Demand Triggers $22M Extension Round
- From Zero To Crypto Hero In 25 Minutes: Changelly Introduces A Free Gamified Crash Course
Comments
No comment